Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb This Week: DNAStar, Ambry, and Oxford Gene Technology

DNAStar Lasergene 14

DNAStar has launched Lasergene 14 software. The update includes three new applications: GenVision Pro, a comprehensive genome browser; NovaDock, a protein-protein docking application; and NovaFold Antibody, a specific antibody structure prediction program. It also includes enhancements to virtual cloning with three new cloning methods, newly integrated combined next-generation sequencing workflows, enhancements to the de novo transcriptome workflow introduced with Lasergene 13, and a workflow in support of Sanger validation of NGS data, the company said.

Ambry Genetics ProstateNext Panel

Ambry Genetics has launched its ProstateNext 14-gene panel for hereditary prostate cancer. The panel evaluates germline ATM, BRCA1, BRCA2, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PALB2, PMS2, RAD51D, and TP53 genes using next-generation sequencing and deletion/duplication analysis to determine disease risk and/or treatment options.

Oxford Gene SureSeq MyPanel NGS Custom Cancer Panels

Oxford Gene Technology has launched its SureSeq myPanel NGS custom cancer panels. The panels are hybridization-based and use a custom set of probes to deliver complete and uniform coverage of genes of interest to users without the need for fill-in Sanger sequencing, the company said. They also include a comprehensive library of gene content which covers key cancer types including, myeloid, chronic lymphocytic leukemia, ovarian, and breast.

For more new products and services, please visit the New Products page on our website.